a cancer medicine oncology therapeutics company, which engages in the development of drugs that target cell division (mitosis), for the treatment of various cancers including leukemia, lymphomas, and solid tumors
Industry Biotechnology
A.I.dvisor indicates that over the last year, CRDF has been loosely correlated with AKBLF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CRDF jumps, then AKBLF could also see price increases.
Ticker / NAME | Correlation To CRDF | 1D Price Change % | ||
---|---|---|---|---|
CRDF | 100% | -4.38% | ||
AKBLF - CRDF | 37% Loosely correlated | -5.04% | ||
ABOS - CRDF | 34% Loosely correlated | +3.16% | ||
RGNX - CRDF | 33% Loosely correlated | +4.40% | ||
VRPX - CRDF | 32% Poorly correlated | +3.95% | ||
MGTX - CRDF | 30% Poorly correlated | -5.68% | ||
More |
Ticker / NAME | Correlation To CRDF | 1D Price Change % |
---|---|---|
CRDF | 100% | -4.38% |
solid tumors theme (2 stocks) | 75% Closely correlated | -11.86% |
medicine theme (3 stocks) | 32% Poorly correlated | -7.66% |
cancer theme (82 stocks) | 29% Poorly correlated | -5.37% |
treatment theme (56 stocks) | 25% Poorly correlated | -4.29% |
drugs theme (254 stocks) | 22% Poorly correlated | -4.03% |
More |